Navigation Links
New funding to research 'super material' graphene
Date:12/27/2012

Scientists at Imperial College London are set to receive over 4.5 million of public funding to investigate how the 'super material' graphene can drive improvements in high-tech industries, such as aerospace design and medical technologies.

The Chancellor of the Exchequer, George Osborne MP, today announced 21.5 million of capital investment to commercialise graphene, one of the thinnest, lightest, strongest and most conductive materials to have been discovered, marked by the 2010 Nobel Prize in Physics as one of the world's most ground breaking scientific achievements.

Three research projects at Imperial will share the Engineering and Physical Sciences Research Council (EPSRC) funding as part of a new programme with a number of industrial partners, including aeroplane manufacturer Airbus. The scientists receiving the grant hope to develop graphene technologies that will contribute to the UK economy and can be applied by industries around the world.

Professor Neil Alford, deputy principal for research in Imperial's Faculty of Engineering, who is playing a key role in one of the new projects, said: "This is a tremendous opportunity for UK science and industry. The new funding will enable us to bring graphene a step closer to useful applications, by helping us explore the physical and mechanical properties of this remarkable material, as well as its behaviour at high frequency."

In one project worth 1.35 million, led by Professor Tony Kinloch from the Department of Mechanical Engineering with colleagues from the Departments of Chemistry and Chemical Engineering, researchers will explore how combining graphene with current materials can improve the properties of aeroplane parts, such as making them resistant to lightning-strikes. They hope the same technology can also be used to develop coatings for wind-turbine blades, to make them scratch resistant and physically tougher in extreme weather conditions.

Professor Eduardo
'/>"/>

Contact: Press Office
press.office@imperial.ac.uk
44-078-038-86248
Imperial College London
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
2. Research and education success earns more NSF funding
3. Auxogyn Completes $20 Million In Series A Funding
4. NeuroPhage Receives Michael J. Fox Foundation Funding for Parkinsons Disease Research
5. AquaLiv Technologies, Inc. and Its Subsidiary, AquaLiv, Inc., Release Funding Updates
6. Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
7. U.S. Senate Urged to Increase Federal Funding for Research into Hereditary Angioedema, a Rare and Serious Genetic Disorder
8. Glythera Relocates to North East as Part of £2M Funding Round
9. Funding boost for silicon carbide super chip
10. Laboratory Decision Makers Cautiously Optimistic about Funding Conditions, Finds Frost & Sullivan
11. Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.H. , May 22, 2013  Superior ... the Year 2013" by Business NH Magazine.  For ... Granite State organizations that distinguish themselves with extraordinary ... very proud to receive this honor," said ... Controls.  "As with any recognition, this award is ...
(Date:5/22/2013)... Switzerland (PRWEB) May 22, 2013 ... for industrial biotechnology, drug discovery, and life science ... Genedata Selector ™ as its bioinformatics platform ... production-relevant organisms. Genedata will provide AB Enzymes, one ... with a hosted solution of Genedata Selector accompanied ...
(Date:5/22/2013)... AudioNotch is the leading ... AudioNotch is pleased to announce a partnership with ... both British Columbia and Alberta, Destination Hearing is ... AudioNotch's tinnitus treatment program is now available at ... Hearing clinic, patients have the detection of their ...
(Date:5/22/2013)... 22, 2013 Express Diagnostics Int’l, ... Ltd are pleased to announce a sponsorship agreement ... and New Zealand distributor of DrugCheck® onsite testing devices, ... participated in the Austin 400 May 17-19 in Austin, ... agreement that involves each car of the Erebus Motorsport ...
Breaking Biology Technology:Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2
... 5, 2011 Debiopharm Group™ (Debiopharm), a ... development and companion diagnostics, today presented the ,JCA-Mauvernay Award, ... Research Institute in Tokyo, for his basic research on ... to Doctor Mineo Kurokawa from the University of Tokyo, ...
... Corporation (NASDAQ: LIFE ) announced today it will ... 25, 2011, after market close. The company will also hold ... to discuss operating results, as well as future expectations. ... can be accessed through the investor relations page of the ...
... Md., Oct. 4, 2011 Northwest Biotherapeutics (OTC.BB: ... be presenting at the second annual Cancer Immunotherapy: ... at the New York Academy of Medicine in ... opinion leaders, industry executives, and other stakeholders to ...
Cached Biology Technology:The Japanese Cancer Association and Debiopharm Group™ Present Doctors Arakawa and Kurokawa With the 2011 'JCA-Mauvernay Award' for Their Innovative and Outstanding Research in the Field of Cancer 2The Japanese Cancer Association and Debiopharm Group™ Present Doctors Arakawa and Kurokawa With the 2011 'JCA-Mauvernay Award' for Their Innovative and Outstanding Research in the Field of Cancer 3Life Technologies Sets 3rd Quarter 2011 Earnings Release Date for Tuesday, October 25, 2011 2NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 2NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 3NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 4
(Date:5/22/2013)... of potential environmental and human health effects from ... year has led scientists to recommend stronger government ... lithium-ion (Li-ion) battery materials. That,s the conclusion of ... Environmental Science & Technology . , Oladele A. ... have become mainstays for powering everything from smart ...
(Date:5/22/2013)... feared Legionella pneumophila bacteria is responsible for ... In order to infect us, this pathogen has developed ... go unnoticed in our cells, thus avoiding these acting ... Basque biosciences research centre, CIC bioGUNE, in which teams ... USA and the National Supercomputation Centre in Barcelona (BSC) ...
(Date:5/22/2013)... 22, 2013 Early screening for prostate cancer could ... is for women, thanks to UC Irvine research published ... Society . , After more than a decade of ... clearly identify clinically usable markers for prostate cancer in ... sooner, with greater accuracy and at dramatically lower cost. ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... cells are often touted as one method to help decrease society,s ... work to be done before fuel cells will be ready for ... power for emergencies. U of C chemists Jeff Hurd and ... fuel cell towards a higher level of design. They have discovered ...
... which could be used to grow tissues such as ... research is highlighted in the latest issue of Business, ... Sciences Research Council (BBSRC). The new structures are ... using proteins from alpha helices one of the ...
... Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing ... today announced the presentation of data from its recently ... augmentation (add-on) treatment in subjects with major depressive disorder, ... treatment with the representative SSRI citalopram hydrobromide. In ...
Cached Biology News:U of C chemists discover recipe to design a better type of fuel cell 2'Spaghetti' scaffolding could help grow skin in labs 2Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 2Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 3
Cytosol/Particulate Rapid Separation Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: 4C...
Request Info...
Purified anti-human CD182 (CXCR2)...
Peptide-affinity Purified Polyclonal Antibody to Purinergic Receptor P2Y12...
Biology Products: